Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. – PubMed – NCBI

Health Hacker Australia > The Science > Ageing, Longevity and disease. > Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. – PubMed – NCBI

Nicotinamide adenine dinucleotide (NAD), the cell’s hydrogen carrier for redox enzymes, is well known for its role in redox reactions. More recently, it has emerged as a signaling molecule. By modulating NAD+-sensing enzymes, NAD+ controls hundreds of key processes from energy metabolism to cell survival, rising and falling depending on food intake, exercise, and the time of day. NAD+ levels steadily decline with age, resulting in altered metabolism and increased disease susceptibility. Restoration of NAD+ levels in old or diseased animals can promote health and extend lifespan, prompting a search for safe and efficacious NAD-boosting molecules that hold the promise of increasing the body’s resilience, not just to one disease, but to many, thereby extending healthy human lifespan.

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. – PubMed – NCBI

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: